Katherine A. Eade Harvard Bioscience Inc (HBIO) insider trading activity

Katherine A. Eade is Director of HARVARD BIOSCIENCE INC. Currently has a direct ownership of 421,126 shares of HBIO, which is worth approximately $168,450. The most recent transaction as insider was on Jul 16, 2025, when has been sold 110,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 421K

0% 3M change

35.36% 12M change

Total Value Held $168,450

Katherine A. Eade Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 16 2025	BUY Grant, award, or other acquisition	-	110,000 Added 20.71%	421,126 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	-	45,872 Added 12.85%	311,126 Common Stock
May 22 2023	BUY Grant, award, or other acquisition	-	25,554 Added 8.79%	265,254 Common Stock
May 24 2022	BUY Grant, award, or other acquisition	-	38,259 Added 13.76%	239,700 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	2,525 Added 1.24%	201,441 Common Stock
Dec 28 2021	BUY Grant, award, or other acquisition	-	1,401 Added 0.7%	198,916 Common Stock
May 25 2021	BUY Grant, award, or other acquisition	-	14,400 Added 6.8%	197,515 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	14,200 Added 7.2%	183,115 Common Stock

Also insider at

VAXX

Vaxxinity, Inc. Healthcare

Director

KAE

Katherine A. Eade

Director

Holliston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Harvard Bioscience Inc insider buys or sells HBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HARVARD BIOSCIENCE INC

Track Activities on HBIO

Account